Is hormonal birth control used to treat premenstrual dysphoric disorder (PMDD)?

Hormonal Birth Control for PMDD

Yes, combined oral contraceptives (COCs) are used to treat PMDD, with drospirenone 3mg/ethinyl estradiol 20mcg in a 24/4 regimen being the most evidence-based option, FDA-approved specifically for this indication. 1, 2

First-Line Hormonal Treatment

The drospirenone/ethinyl estradiol 24/4 regimen is the only COC FDA-approved for PMDD treatment and demonstrates superiority over placebo across multiple symptom domains 1, 2:

• Improves overall premenstrual symptoms with small to moderate effect sizes (standardized mean difference -0.41) 1
• Reduces functional impairment in productivity, social activities, and relationships (mean differences ranging from -0.29 to -0.31) 1
• Addresses specific symptom clusters including negative emotions, food cravings, and water retention-related symptoms, with greatest improvements achieved within the first treatment cycle and sustained through cycles 2-3 3
• Response rates reach 39-58% compared to 36% with placebo 1

Alternative Hormonal Options

When the standard drospirenone/EE formulation is not suitable:

• Nomegestrol acetate 2.5mg/17-beta estradiol 1.5mg shows promise with 74.5% of women reporting positive mood response and 63.3% adherence rates, though this requires further randomized controlled trial validation 4
• Other monophasic extended-cycle COCs with less androgenic progestins may help, though evidence is limited 5

Contraceptive Methods to Avoid in PMDD

Progestin-only methods have potential to worsen mood symptoms and should be approached with extreme caution 5:

• Progestin-only pills, levonorgestrel IUDs, etonorgestrel implants, and depot medroxyprogesterone acetate can negatively affect mood in women with baseline mood disorders including PMDD 5
• If these methods are chosen, close follow-up and careful counseling are mandatory 5
• Copper IUDs are recommended for those not seeking hormonal contraceptives 5

Comparative Effectiveness

Recent network meta-analysis shows drospirenone/EE 24/4 regimen is the most effective COC, with particularly positive outcomes for both physical and emotional symptoms 6. However, continuous paroxetine (an SSRI) showed the greatest effect across all symptom domains when comparing antidepressants to COCs 6.

Important Caveats

Adverse effects are more common with hormonal treatment 1:

• Withdrawal rates due to adverse effects increase from 3% (placebo) to 6-16% with drospirenone/EE 1
• Total adverse effects occur in 40-54% versus 28% with placebo 1
• Common side effects include breast pain, nausea, intermenstrual bleeding, and menstrual disorders 1
• No serious adverse events (such as venous thromboembolism) were reported in included trials, though standard COC contraindications apply 1

Treatment Selection Algorithm

Choose hormonal contraception for PMDD when:

1. Patient desires contraception and has no COC contraindications 2
2. Physical symptoms predominate alongside emotional symptoms (drospirenone/EE 24/4 particularly effective) 3, 6
3. Patient prefers non-psychotropic treatment or has failed/refused SSRIs 6
4. Reproductive planning makes hormonal contraception desirable 5

Treatment choice should prioritize predominant symptom patterns, individual tolerability, and reproductive planning needs 6.